Louis Lucido
Equibles does not estimate personal net worth.
About Louis Lucido
BioCorRx Inc. reported in an 8-K filed January 5, 2024 that Louis Lucido was appointed President, effective February 1, 2024. BioCorRx Inc. reported in an 8-K filed January 5, 2024 that Louis Lucido was appointed Interim President, effective January 5, 2024. BioCorRx Inc. is classified in the Medical Care Facilities industry within the Healthcare sector. Other leadership on record at BioCorRx Inc. includes Lourdes Felix (CEO), Harsha Murthy (Board Member) and Joseph J. Galligan (Board Member).
“On January 5, 2024, in light of the Granier Resignation, the Board appointed Louis Lucido as Interim President of the Company, effective immediately through January 31, 2024, and transitioning to President on February 1, 2024 (the “Lucido Appointment”).”
“On January 5, 2024, in light of the Granier Resignation, the Board appointed Louis Lucido as Interim President of the Company, effective immediately through January 31, 2024, and transitioning to President on February 1, 2024 (the “Lucido Appointment”).”
Affiliation history
-
BioCorRx Inc. (BICX)
SEC 8-K
Current2024-02-01–present
Company network
Leadership on record at BioCorRx Inc.
- Lourdes Felix CEO
- Harsha Murthy Board Member
- Joseph J. Galligan Board Member